2-(diphenylphosphanyl)benzoic acid allyl ester | 627106-31-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(diphenylphosphanyl)benzoic acid allyl ester
• 英文别名: allyl 2-diphenylphosphinobenzoate；allyl o-(diphenylphosphanyl)benzoate；Prop-2-enyl 2-diphenylphosphanylbenzoate
• CAS: 627106-31-4
• 化学式: C₂₂H₁₉O₂P
• 分子量: 346.365
• InChiKey: DANLWNKZYCMMMX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  25
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(4-azidophenyl)-2-(morpholin-4-yl)ethanone 、 2-(diphenylphosphanyl)benzoic acid allyl ester 以 四氢呋喃 、 水 为溶剂， 反应 1.5h， 以64.4%的产率得到2-(diphenylphosphinoyl)-N-[4-(2-(morpholin-4-yl)acetyl)phenyl]benzimidic acid allyl ester
  参考文献：
  名称：

  Conversion of Aryl Azides to O-Alkyl Imidates via Modified Staudinger Ligation

  摘要：

  o-Carboalkoxy triarylphosphines are shown to react with aryl azides to provide Staudinger ligation products bearing O-alkyl imidate linkages. This is in contrast to alkyl azides whose ligation to o-carboalkoxy triarylphosphines has been reported to yield amide-linked materials. This extension of the Staudinger ligation for coupling of abiotic reagents under biocompatible conditions highlights the utility of commercially available triarylphosphines through which suitable linkers can be attached via an ester moiety.

  DOI：

  10.1021/ol035635s
• 作为产物：
  描述：

  2-二苯基膦苯甲酸 、 烯丙醇 在 4-二甲氨基吡啶 、 N,N'-二环己基碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 以96%的产率得到2-(diphenylphosphanyl)benzoic acid allyl ester
  参考文献：
  名称：

  2-取代的烯丙基-DPPB酯的定向支化区域选择性加氢甲酰化

  摘要：

  烯丙基 o-DPPB 酯的支化区域选择性加氢甲酰化已经用单取代和双取代的烯烃官能团完成，收率和选择性都非常好。优化的反应条件允许甚至三取代的烯烃官能团反应。这些反应是催化剂导向的 o-DPPB 基团发挥显着加速作用的结果，例如香叶基和橙花基 o-DPPB 酯的高度位置、区域和非对映选择性加氢甲酰化。 (© Wiley -VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007)

  DOI：

  10.1002/ejoc.200700120

文献信息

• [EN] COMPOUNDS COMPRISING CLEAVABLE LINKER AND USES THEREOF<br/>[FR] COMPOSÉS COMPRENANT UN LIEUR CLIVABLE ET LEURS UTILISATIONS
  申请人：INTOCELL INC

  公开号：WO2019008441A1

  公开（公告）日：2019-01-10

  Provided are a compound including a cleavable linker, a use thereof, and an intermediate compound for preparing the same, and more particularly, the compound including a cleavable linker of the present invention may include an active agent (for example, a drug, a toxin, a ligand, a probe for detection, etc.) having a specific function or activity, a SO2 functional group which is capable of selectively releasing the active agent, and a functional group which triggers a chemical reaction, a physicochemical reaction and/or a biological reaction by external stimulation, and may further include a ligand (for example, oligopeptide, polypeptide, antibody, etc.) having binding specificity for a desired target receptor.

  提供了一种包括可切割连接物的化合物，其用途，以及用于制备该化合物的中间体化合物，更具体地，本发明的包括可切割连接物的化合物可能包括具有特定功能或活性的活性剂（例如，药物，毒素，配体，用于检测的探针等），能够选择性释放活性剂的SO2官能团，以及通过外部刺激触发化学反应，物理化学反应和/或生物反应的官能团，并且还可以包括具有与所需靶受体结合特异性的配体（例如，寡肽，多肽，抗体等）。
• Heterodimerization of Olefins. 1. Hydrovinylation Reactions of Olefins That Are Amenable to Asymmetric Catalysis
  作者：T. V. RajanBabu、Nobuyoshi Nomura、Jian Jin、Malay Nandi、Haengsoon Park、Xiufeng Sun

  DOI：10.1021/jo035171b

  日期：2003.10.1

  counteranion (BARF or SbF6) in an enantioselective version of the Ni-catalyzed reaction raises the prospects of developing a practical route for the synthesis of 3-arylbutenes. Several pharmaceutically relevant compounds, including widely used 2-arylpropionic acids, can be synthesized from these key intermediates. This reaction appears to be quite general. Synthesis of several new 2-diphenylphosphino-1

  通过对配体和抗衡离子作用的系统检查，发现了用于乙烯和各种功能化乙烯基芳烃的近定量和高度选择性共聚的新方案。在典型的反应中，在-56℃下，在[CH2Cl2]中，在[CH3Cl2]中分别存在0.0035当量的[（烯丙基）NiBr] 2，三苯膦和AgOTf，4-溴苯乙烯和乙烯进行共二聚，得到3-（4-溴苯基）-1 -丁烯的收率和选择性均> 98％。与[（烯丙基）PdX] 2的相应反应效率低下且选择性低，在鉴定出可行的系统之前可能需要进一步优化。产生可比的产率和选择性的另一有用方案涉及使用由2-二苯基膦基苯甲酸烯丙酯，Ni（COD）2和（C 6 F 5）3 B制备的单组分催化剂。识别手性半不稳定配体（例如，（R）-2-甲氧基-2'-二苯基膦基-1,1'-联萘基，MOP）与高度离解的抗衡阴离子（BARF或SbF6）之间的协同关系Ni催化的反应的发展提出了开发合成3-芳基丁烯的实用路线的前景。可以从这
• [EN] 1,4,7,10-TETRAZACYCLODODECANE BASED AGENTS TO TARGET BACTERIA AND ITS USE<br/>[FR] AGENTS À BASE DE 1,4,7,10-TÉTRAZACYCLODODÉCANE POUR CIBLER DES BACTÉRIES ET LEURS UTILISATIONS
  申请人：HELMHOLTZ ZENTRUM FÜR INFEKTIONSFORSCHUNG GMBH

  公开号：WO2016026841A1

  公开（公告）日：2016-02-25

  The present invention relates to new compounds comprising a siderophore moiety as well as a core structure able to chelate a metal ion. Optionally, the compounds may have additionally a moiety with a functional element including a marker molecule, a bioactive agent, an activity based probe suitable to monitor the aberrant expression or activity of proteins involved in the initiation and progression of bacterial infection, or a compound useful for bacterial inhibition. In a further aspect, the present invention provides a pharmaceutical composition containing said compound, for example, said pharmaceutical composition is an antibiotic. Additionally, the present invention relates to the use of said compounds in diagnostic methods, in particular, imaging methods including SPEC, PET or MRI. In an embodiment of the present invention, the compound is part of a theranostic composition having both, therapeutic as well as diagnostic activities.

  本发明涉及包含一种铁载体基团以及能够螯合金属离子的核心结构的新化合物。选项地，这些化合物可能还具有包含标记分子、生物活性物质、适用于监测参与细菌感染起始和进展的蛋白质异常表达或活性的活性探针，或者适用于细菌抑制的功能元素的基团。此外，本发明还提供含有所述化合物的药物组合物，例如，所述药物组合物是抗生素。此外，本发明还涉及在诊断方法中使用所述化合物，特别是包括SPEC、PET或MRI的成像方法。在本发明的一个实施例中，该化合物是一种具有治疗和诊断活性的治疗组合物的一部分。
• [EN] MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION<br/>[FR] GRILLES LOGIQUES MOLÉCULAIRES POUR LA DÉGRADATION CONTRÔLÉE DE MATÉRIAU
  申请人：UNIV WASHINGTON

  公开号：WO2018057941A1

  公开（公告）日：2018-03-29

  The present disclosure features, inter alia, a cyclic multifunctional linker, including at least two cleavable moieties; at least two connecting chains connected to the at least two cleavable moieties to provide a cyclic structure; and at least two linking groups, each linking group being bonded at one end to a connecting chain and being located between two cleavable moieties, and each linking group having a second end configured to bond to crosslinkable moieties. In the cyclic multifunctional linker, each connecting chain has at least two ends, and at least two of the connecting chains are each connected at each end to a cleavable moiety.

  本公开涵盖了一个循环多功能连接物，包括至少两个可切断的基团；至少两个连接链连接到至少两个可切断的基团以提供一个循环结构；以及至少两个连接基团，每个连接基团在一端连接到一个连接链，并位于两个可切断的基团之间，每个连接基团具有第二端配置为与可交联基团结合。在循环多功能连接物中，每个连接链具有至少两个端点，并且至少两个连接链中的每一个端点都连接到一个可切断的基团。
• [EN] DOTAM DERIVATIVES FOR THERAPEUTIC USE<br/>[FR] DÉRIVÉS DE DOTAM À USAGE THÉRAPEUTIQUE
  申请人：SANOFI SA

  公开号：WO2015075699A1

  公开（公告）日：2015-05-28

  The present invention relates to A compound of the formula I, in any of their stereoisomeric forms or a mixture of stereoisomeric forms in any ratio, and the pharmaceutically acceptable salts thereof, (I) wherein M is absent or present and a positively charged metal ion out of the group Gd, Yb, Mn, Cr, Cu, Fe, Pr, Nd, Sm, Tb, Yb, Dy, Ho, Er, Eu, Ga, 68Ga, 64Cu, 99mTc, 177Lu, 67Ga, 111In, 99Mo; and A1, A2, A3 and A4; L1, L2, L3 and L4; Y1, Y2, Y3 and Y4; Z1, Z2, Z3 and Z4 have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds and are suitable for the treatment of osteoarthritis. The invention furthermore relates to processes for the preparation of the compounds of the formula I, their use as pharmaceuticals, and pharmaceutical compositions comprising them.

  本发明涉及公式I的化合物，其具有任何立体异构形式或任何比例的立体异构形式的混合物，以及其药学上可接受的盐，其中M不存在或存在，并且是来自组Gd、Yb、Mn、Cr、Cu、Fe、Pr、Nd、Sm、Tb、Yb、Dy、Ho、Er、Eu、Ga、68Ga、64Cu、99mTc、177Lu、67Ga、111In、99Mo中的一种正电荷金属离子；以及A1、A2、A3和A4；L1、L2、L3和L4；Y1、Y2、Y3和Y4；Z1、Z2、Z3和Z4在索权中指示的含义。公式I的化合物是有价值的药理活性化合物，适用于治疗骨关节炎。此外，该发明还涉及公式I的化合物的制备方法，它们作为药物的用途，以及包含它们的药物组合物。